- Child and Adolescent NeuroDevelopment Initiative (CANDI)
- Center for Autism and Neurodevelopmental Disorders (CANDO)
- Center for Developmental Disabilities Evaluation and Research (CDDER)
- Health Surveillance for Adults with Intellectual Disability
- Oral Health Disparities
- MA DDS Prevention Conference
- Preventive Health Screenings for Adults with Intellectual Disabilities
- Mortality Review
- Quality Assurance Reports
- Webinars
- Pica
- Constipation and Bowel Obstructions
- Substance Abuse in the Workplace
- Dysphagia, Aspiration, and Choking
- Oral Health Practices
- DDS Safe Transportation of People in Wheelchairs
- Falls Prevention and Intervention Strategies
- Human Rights Training for Self-Advocates
- Human Rights: What Families Need to Know
- Identifying, Healing, and Preventing Pressure Ulcers
- MAP Training Resources
- Adjunct RIA Training Materials
- Clozapine Therapy Training
- DDS MAP Training Resources
- DMH/DCF MAP Training Resources
- Instructions for Virtual Certification Testing
- MAP Curriculum and Adjunct Training Materials
- MedSoft© Version 7.0
- Responsibilities in Action Curriculum and Training Materials
- Semiannual MAP Trainer Webinar Fall 2017
- Semiannual MAP Trainer Webinar Fall 2019
- Semiannual MAP Trainer Webinar Spring 2018
- Spring 2020 MAP Trainer Webinar
- TestMaster Universe
- Warfarin Sodium Therapy Training
- Mandated Reporting of Abuse and Mistreatment
- Recognizing and Reporting Financial Abuse
- Widening the Circle: Expanding Opportunities for Friendship
- Risk Management in Developmental Disabilities
- Understanding and recognizing dementia in IDD
- Aging with Intellectual and Developmental Disability Trainings
- Adapting to Age-Related Changes in the Home, Day Program, and Community
- Aging and Disability Resource Consortia
- General Aging
- Dementia and IDD
- Launching a Memory Café
- Life Sustaining Treatment Policy
- Guardianship and Aging in Intellectual Disabilities Part I
- Guardianship and Aging in Intellectual Disabilities Case Studies Part II
- Massachusetts Medical Orders for Life Sustaining Treatment (MOLST)
- End of Life Definitions
- Five Wishes
- Fostering Social Inclusion and Community Engagement
- Presentations & Publications
- Our Team
- Child and Adolescent Needs and Strengths (CANS) Program
- Division of Neuroinformatics
- Healthy People/Healthy Communities
- INDEX
- Insurance Resource Center for Autism & Behavioral Health
- Laboratory for Equity in Autism Dissemination (LEAD) Lab
- Leadership Education in Neurodevelopmental and Related Disabilities (LEND)
- Neurobehavioral Science and Neurogenetics
- Pathways to Inclusive Health Care Program
- Sibling Support
Neurobehavioral Technologies Research
Current projects and developing areas of investigation include:
- Measuring levels of excitatory and inhibitory neurotransmitters in the brain using specialized magnetic resonance imaging techniques, and examining how these neurotransmitter levels are connected to social cognition in autism spectrum disorder. (PI: Cochran)
- Evaluating the effect of a medication, gabapentin, on excitatory and inhibitory neurotransmitters in the brain of individuals with autism spectrum disorder. (PI: Cochran)
- Using electroencephalography (EEG) and functional near-infrared spectroscopy to characterize deficits in social engagement in autism spectrum disorders to more accurately assess ASD and to develop improved behavioral therapy methods. (PI: Modarres)
- Applied virtual reality, augmented reality and 3D gaming to understand and assist individuals with autism spectrum disorders, families and care providers with daily living, learning, empathy, and other areas. (PI: LeMoine)
- Neurobehavioral Evaluation of Schizophrenia
We employ neurocognitive measures of frontal lobe function to evaluate individual differences among individuals with IDD. These provide the basis to characterize neurobehavioral functional levels among individuals and within psychiatric diagnostic groups. (Curtis Deutsch) - Investigating Shared Neurobiological Mechanisms of Autism and Schizophrenia
We study developmental biological measures among individuals with IDD, in order to determine which characteristics are distinctive to specific diagnoses and which are shared by differing psychiatric diagnoses. (Curtis Deutsch) - Objective Diagnosis of Developmental Variation in Chromosomal Syndromes
This initiative focuses on developmental abnormalities within IDD. A number of IDD genetic disorders are characterized by distinctive features of the head and face; a common example is Down syndrome (trisomy of chromosome 21). To provide quantitative identification of these features, we have been developing 3D imaging methods to identify these features objectively and reliably. (Curtis Deutsch)